Biotech · Private company
Tisento Therapeutics
Track this companyFree. Adds Tisento Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CY6463Phase 2 · Alzheimer's Disease With Vascular PathologyClinicalTrials.gov · fetched Nov 12, 2026
- IW-6463 TabletsPhase 2 · MELASClinicalTrials.gov · fetched Nov 12, 2026
- zagociguat 15mgPhase 2 · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)ClinicalTrials.gov · fetched Nov 12, 2026
- zagociguat 30mgPhase 2 · Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)ClinicalTrials.gov · fetched Nov 12, 2026
- CY6463Phase 1 · SchizophreniaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)PHASE2 · TERMINATED · started Aug 18, 2025ClinicalTrials.gov NCT06961344 · fetched Nov 12, 2026
- A Phase 2b Study of Zagociguat in Patients With MELASPHASE2 · COMPLETED · started Sep 10, 2024ClinicalTrials.gov NCT06402123 · fetched Nov 12, 2026
- A Study of the Effects of CY6463 in Participants With Alzheimer's Disease With Vascular PathologyPHASE2 · TERMINATED · started Nov 2, 2021ClinicalTrials.gov NCT04798989 · fetched Nov 12, 2026
- Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable SchizophreniaPHASE1 · COMPLETED · started Sep 10, 2021ClinicalTrials.gov NCT04972227 · fetched Nov 12, 2026
- Phase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)PHASE2 · TERMINATED · started Nov 13, 2020ClinicalTrials.gov NCT04475549 · fetched Nov 12, 2026